Figure S1 from HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung Cancer
Published in 2023 by
Kimio Yonesaka,
Junko Tanizaki,
Osamu Maenishi,
Koji Haratani 
,
Hisato Kawakami,
Kaoru Tanaka,
Hidetoshi Hayashi,
Kazuko Sakai,
Yasutaka Chiba,
Asuka Tsuya,
Hiroki Goto,
Eri Otsuka,
Hiroaki Okida,
Maki Kobayashi,
Ryoto Yoshimoto
and other authors.
,
Hisato Kawakami,
Kaoru Tanaka,
Hidetoshi Hayashi,
Kazuko Sakai,
Yasutaka Chiba,
Asuka Tsuya,
Hiroki Goto,
Eri Otsuka,
Hiroaki Okida,
Maki Kobayashi,
Ryoto Yoshimoto
and other authors.
